Babies born on or after 1 August 2024 will receive the injection during a visit to the maternity and child health clinic in October and November. In the future, HUS will administer the medicine at the maternity hospital during the discharge examination.
Additionally, HUS provides the medicine to children under 1 year of age who are at risk for severe RSV infections.
For more information on preventing RSV infections, please contact the public health nurse at your maternity and child health clinic.
The medicine against RSV provides good protection
RSV is the leading cause of respiratory infections that result in hospitalisation among young children worldwide. The medicine developed against RSV aims to prevent the majority of serious illnesses and hospitalisations in infants caused by the virus. It offers good protection throughout the winter epidemic season.
